Viagra for the Ladies?
Did you know that there's a condition called "hypoactive sexual desire disorder," from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue.
Did you know that there’s a condition called “hypoactive sexual desire disorder,” from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue. –KA
TRUTHDIG’S JOURNALISM REMAINS CLEARNizagara-online.net via Gawker:
“We have to give women some type of option,’’ said Beverly Whipple, a professor emeritus at Rutgers University and an expert on women’s sexual health. “I’m hoping this will help the women who need it.’’
One expert, Andrew Goldstein who runs the Sexual Wellness Center in Annapolis, Md., described a “huge’’ unmet need for a medical treatment.
Women who took the medicine, known as flibanserin, reported 22 percent more “satisfying sexual events” than those given a placebo in two clinical tests of 1,378 patients, according to abstracts released today at the European Society for Sexual Medicine annual meeting in Lyon, France.
The storytellers of chaos tried to manipulate the political and media narrative in 2025, but independent journalism exposed what they tried to hide.
When you read Truthdig, you see through the illusion.
Support Independent Journalism.
Health & Wellness
Critics say ending the decades-old practice would likely shield the agency’s decisions from public scrutiny.
Book Excerpt
Seventy-five years ago in Chicago, a conservative project was hatched to cure classical economics of its aversion to patents and monopolies. The drug companies were its first and biggest beneficiaries.
Business & Economy
The pharmaceutical giant refuses to make its vaccine technology available to all.
The opioid-pushing pharmaceutical companies may finally be forced to pay some of their billions to help remediate the crisis they helped manufacture. The state of Oklahoma won a big court victory against Johnson & Johnson, the huge corporation that downplayed the risks of opioids while keeping the country awash in their deadly product. Johnson & Johnson and […]
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.